×
Back to Agenda
FDA Rare Disease Town Hall
Session Chair(s)
James Valentine, JD, MHS
Director, Hyman, Phelps & McNamara, PC, United States
Hear from senior FDA leadership about challenges and opportunities in reviewing drugs for rare diseases. Representatives from key Agency Offices/Centers will provide updates on key trends and initiatives, then will discuss hot topic questions.
Learning Objective : Discuss recent trends in the development and FDA review of orphan drugs; Explain new and ongoing FDA policies and initiatives to facilitate the development of drugs for rare diseases; Identify opportunities to further address the challenges associated with rare disease medical product development.
Speaker(s)
Panelist
Assoc. Dir. for Rare Diseases; Program Manager, Accelerating Rare Disease Cures , FDA, United States
Panelist
Senior Vice President, Molecule Discovery and Head of Infectious Disease, Eli Lilly and Company, United States
Have an account?